Landmark Clinical Trial Shows Value of Immunotherapy for… : Oncology Times
An abstract is unavailable.
Related Articles
Government Funding for the Development of Enzalutamide
This cross-sectional study assesses the various patents and US government grants that were critical to the publicly funded development of the cancer drug enzalutamide.
Pembrolizumab/Chemo, Followed by Olaparib Maintenance, Boosts PFS in Advanced Ovarian Cancer
Pembrolizumab plus chemotherapy, followed by olaparib with or without bevacizumab, improved PFS in advanced ovarian cancer.
Primary large B-cell lymphomas of immune-privileged sites
Edited by Associate Editor Michael Hallek and Podcast Editor Laurie H. Sehn, this Review Series highlights the biologic features of, clinical phenotype of,
AACR Grantee Studies a Rare Form of Sarcoma
Small donations to the AACR add up to big support for promising research on treatment of a sarcoma that strikes teenagers and young adults.
Selinexor Plus Ruxolitinib Displays Activity in Ruxolitinib-Pretreated Myelofibrosis
Selinexor plus ruxolitinib showed activity in patients with myelofibrosis who were treated with ruxolitinib.
Immune reconstitution and evolution of B-cell–stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL
Key PointsLymphopenia is transient with a persistent lack of effector B cells causing no excess late infectious mortality after R-CHOP for HIV-DLBCL.R-IPI,
Daratumumab Significantly Improves PFS, Extends OS in Smoldering Myeloma
Subcutaneous daratumumab reduced the risk for disease progression or death vs active monitoring in intermediate- or high-risk smoldering multiple myeloma.
Behind the Scenes: Patient Education and Decision-Making for CAR T
Panelists discuss how health care providers engage in vital conversations with patients about CAR T therapy, focusing on comprehensive education, emotional support, and clear communication…
Pancreatic ductal adenocarcinoma staging: a narrative… : International Journal of Surgery
lving tools in select patients. The National Comprehensive Cancer Network (NCCN) guidelines define resectability criteria based on tumor involvement of the arteries and veins and…
Stay Updated: December 2024 News from AHNS – Corrected Meeting Dates!
Email from American Head and Neck Society This year, many of our AHNS Sections and Services have been working tirelessly to deliver top-notch educational…
